A Real-World Study of Optimal Treatment with Anlotinib First-Line Therapy in Advanced Hepatocellular Carcinoma

Li Q, Su T, Zhang X, Pan Y, Ma S, Zhang L, Zhang X, Gao X

Cancer Management and Research 2022, 14:3037-3046

Published Date: 20 October 2022